Tumor microenvironment plays a critical role in regulating tumor progression by secreting factors that mediate cancer cell growth. Stromal fibroblasts can promote tumor growth through paracrine factors; however, restraint of malignant carcinoma progression by the microenvironment also has been observed. The mechanisms that underlie this paradox remain unknown. Here, we report that the tumorigenic potential of breast cancer cells is determined by an interaction between the Robo1 receptor and its ligand Slit2, which is secreted by stromal fibroblasts. The presence of an active Slit2/Robo1 signal blocks the translocation of ȕ-catenin into nucleus, leading to down-regulation of c-myc and cyclin D1 via the PI3K pathway.
antigen-antibody complex was immobilized with A/G beads for 2 hr at 4 . After washed with wash buffer (150 mM NaCl, 10 mM Tris pH 7.5, 2 mM Mg 2 Cl 2 and 0.1% Triton X-100 ), proteins were eluted by addition of loading dye and boiling at 95°C for 2 min. The proteins were subjected to SDS-PAGE analysis followed by immunoblotting with various antibodies.
Immunofluorescence
Control and shRobo1 of MDA-MB-231 cells were seeded on coverslips and treated with rSlit2.
The cells were washed with PBS, fixed in 4% paraformaldehyde for 10 min, washed with PBS and permeabilized in 0.2% Triton X-100 for 15 min. After washed with PBS, cells were blocked with PBS containing 10% FBS for 2 hr before incubation with the primary antibody as indicated anti-β-catenin overnight at 4 . The cells were incubated for 1 hr with a fluorochromeconjugated secondary antibody (Alexa Fluor 488 anti-mouse). Coverslips with stained cells were then washed with PBS, stained with 4',6-Diamidino-2-phenylindole (DAPI), and mounted onto glass slides with Vectashield mounting medium (Vector Laboratories, Burlingame, CA). For the primary tumor tissue sections, 100 EDTA buffer was used for heat induced antigen retrieval.
Slides were blocked in PBS containing 10% FBS and then incubated with primary antibodies against Slit2 (Sigma) and α-smooth muscle actin (α-SMA, Dako) overnight at 4 . The slides were incubated for 1 hr with fluorochrome-conjugated secondary antibody (Alexa Fluor 488 anti-mouse or Alexa Fluor 594 anti-rabbit). Slides were then stained with DAPI, and mounted onto glass slides with mounting medium.
Statistical methods
For soft agar colony formation and tumorigenicity assay, all data were presented as means ± SD, and Student's t-test was used to compare control and treatment groups. Asterisk (*) indicated statistical significance with p-value < 0.05. Asterisk (**) indicated statistical significance with p-value < 0.01. The association between Robo1 gene expression and survival of breast cancer patients was estimated using univariate Cox proportional-hazards regression analysis, while the association among survival, Robo1 gene expression and other clinical predictors including age, tumor size, distant metastasis, lymph-node status, tumor grade, estrogen receptor expression, and Her2/neu expression was analyzed by multivariate Cox regression analysis. Hazard ratio was evaluated using the method of Grambsch and Therneau. No violation of the proportional assumption was detected. The optimal cutoff point of Robo1 gene expression for 5-year survival was determined by ROC analysis. The survival curve and the statistics were generated by Kaplan-Meier method and log-rank test, respectively (16). The correlation between Slit2 gene expression and lymph node metastasis after adjustment for other clinical predictors was estimated using partial Pearson's correlation.
Results

Stromal fibroblasts can either suppress or promote tumorigenicity of breast cancer cells
Initially, we determined how stromal fibroblasts affect breast cancer cell tumorigenic activity by performing a series of soft agar colony formation assays using a bottom agar layer containing fibroblasts and an upper agar layer containing breast cancer cells (hereafter referred to as coculture). MDA-MB-231 and SKBR3 were co-cultured with primary fibroblasts (carcinomaassociated fibroblasts, CAF; normal breast-associated fibroblasts, NAF) isolated from breast cancer patients. Surprisingly, two opposite phenotypes were observed that stromal fibroblasts suppressed colony formation in MDA-MB-231 cells but promoted it in SKBR3 (Fig.1A and 1B) . Suppression was also observed in additional breast cancer cell lines including MDA-MB-361, Hs578T and MDA-MB-157 (Fig. 1C) , while promotion was observed in BT20, HCC1937 and MDA-MB-468 cell lines (Fig. 1D) . Furthermore, these opposite phenotypes were also observed when cancer cells were co-cultured with immortalized human CAFs (199Ct) and human fibroblast cell lines (WI38 and Hs68). The colony formation of MDA-MB-231 was reduced (Fig.   1E ), but increased in SKBR3 (Fig. 1F) . These results suggested that fibroblasts could either promote or suppress tumorigenic activity of different breast cancer cells.
Identification of Robo1 as a candidate receptor for fibroblast-associated tumor suppression
The design of the co-culture system strongly suggested that the suppression mechanism is most likely to be mediated by signaling through soluble factors secreted by fibroblasts to the receptors on breast cancer cells. To identify potential receptor, we used human cDNA microarrays to compare the mRNA expression profiles among MDA-MB-231, MDA-MB-361, Hs578T and SKBR3 cells ( Fig. 2A) . Of the 610 genes that are up-regulated in MDA-MB-231, MDA-MB-361 and Hs578T cells compared to SKBR3 cells, eight encoded receptors (Fig. 2B) . qRT-PCR analysis confirmed the expression profiles of these eight receptors to be similar to that of the cDNA microarrays ( Robo2 and Robo4 were ubiquitously expressed in all breast cancer cell lines tested ( Fig. 2D and   E ), suggesting that Robo1 may be the differentially expressed receptor mediating fibroblast suppression in certain breast cancer cell lines.
Robo1 mediates fibroblast-associated tumor suppression
To directly test whether Robo1 plays such a role in fibroblast-mediated suppression of breast tumorigenicity, we established two independent clones of MDA-MB-231 cells with Robo1 depleted using a lentivirus shRNA system (Fig 3A) . The colony formation of these two clones was greatly enhanced in fibroblast co-culture assay compared to the parental control (Fig. 3B) .
Furthermore, co-injection of Robo1-depleted MDA-MB-231 cells with 199Ct into fat pads of NOD/SCID mice generated significantly larger tumors compared to the parental MDA-MB-231 control ( Fig. 3C and Supplementary Fig. S1A ). Identical results were also observed when MDA-MB-157 cells were used ( Fig. 3D and E) . Moreover, depletion of Robo2 had no effect on colony forming activity of MDA-MB-231 cells ( Supplementary Fig. S2 ), confirming the differentially expressed Robo1 is the key player. Conversely, ectopic expression of Robo1 in BT20 and HCC1937 cells (Fig. 3F) , which had low endogenous Robo1 expressions and failed to suppress colony forming abilities, resulted in a significant decrease in colony formation (Fig. 3G) .
Consistently, co-injection of HCC1937 cells expressing Robo1 with fibroblasts into NOD/SCID mice fat pads generated much smaller tumors compared to the parental HCC1937 cells (Fig. 3H and Supplementary Fig. S1B ). Taken together, these results indicated that the presence of Robo1 in cancer cells plays a critical role in fibroblast-mediated suppression of tumorigenesis.
Slit2 secreted from stromal fibroblasts inhibits tumorigenesis via Robo1 receptor
It has been reported that Slit2 serves as a Robo1 ligand in central nervous system to exhibit midline repellent (19, 20) . Expression of Slit2 from fibroblasts may be responsible for the Robo1 further confirmed the Robo1-p85 interaction ( Supplementary Fig. S4 ). The phospho-Akt activity was also decreased in rSlit2 treated control cells, but not the Robo1-depleted cells (Fig. 5B , lanes 1 vs. 2 and lanes 3 vs. 4, respectively). Consistently, using cellular fractionation and immunoblotting, we found that the amount of nuclear ȕ-catenin was reduced in the control cells but not the Robo1-depleted cells when co-cultured with 199Ct (Fig. 5C, lanes 7 & 8) although the ȕ-catenin expression levels were comparable between the control and Robo1-depleted cells (Supplementary Fig S5) . Supportively, upon rSlit2 treatment, an enhanced nuclear localization of ȕ-catenin in the Robo1-depleted cells was detected by immunofluorescence assay (Fig. 5D ), whereas the expression of cyclin D1 or c-myc in cells expressing Robo1 was reduced about 2 folds (Fig. 5E ). Conforming to these findings, reduction of nuclear ȕ-catenin was observed in tumor specimens with either high Robo1 expression in cancer cells or high Slit2 expression in stromal fibroblast (Supplementary Fig. S6 ). Together, these results suggested that activation of Slit2/Robo1 signaling inhibits the PI3K/Akt pathway to block ȕ-catenin nuclear translocation and down-regulate cyclin D1 and c-myc expression (Fig. 5F ).
High expression of either Robo1 in breast cancer cells or Slit2 in stromal fibroblasts is associated with better breast cancer prognosis
The above results imply that the Slit2/Robo1 pathway plays an essential role in fibroblastmediated tumor suppression. We then analyzed the expression levels of Robo1/Slit2 in three cohorts of breast cancer patient specimens (Supplementary Table 2 27) . In this communication, we found that stromal fibroblasts enhanced tumorigenic activity of some breast cancer cells including BT20, HCC1937 and SKBR3, while suppressed others including MDA-MB231, MDA-MB361 and Hs578T (Fig. 1) . The latter cancer cell group expressed Robo1 receptor, which recognizes ligand, Slit2, predominantly secreted from stromal fibroblasts (Fig 4) . Presence of an active Slit2/Robo1 signaling inhibited the PI3K pathway by interacting with its subunit, p85, which led to inhibition of Akt phosphorylation, β-catenin translocation and c-myc and cyclin D1 expression (Fig. 5) . These results explain, in part, how specific stromal fibroblasts expressing Slit2 can restrain a given kind of cancer cell expressing Robo1 from progression. 
